Recent Advances in the Management of Localized and Locally Advanced Renal Cell Carcinoma: A Narrative Review

References

• World Health Organization. Kidney: Intenational Agency for Research on Cancer ; 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/29-Kidney-fact-sheet.pdf. Accessed March 16, 2022.
   Google Scholar
• Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol. 2017;71(4):606–617. doi:10.1016/j.eururo.2016.08.060
   PubMed Web of Science ®Google Scholar
• Campell SC, Clark PE, Chang SS, et al. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline Part I. J Urol. 2021;206:199. doi:10.1097/JU.0000000000001911
   PubMedGoogle Scholar
• Campbell SC, Uzzo RG, Karam JA, et al. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline: part II. J Urol. 2021;206:209. doi:10.1097/JU.0000000000001912
   PubMedGoogle Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399–410. doi:10.1016/j.eururo.2022.03.006
   PubMed Web of Science ®Google Scholar
• Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS. Urologic Diseases in America Project. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2008;112(3):511–520. doi:10.1002/cncr.23218
   PubMed Web of Science ®Google Scholar
• Kim SP, Thompson RH, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012;188(1):51–57. doi:10.1016/j.juro.2012.03.006
   PubMed Web of Science ®Google Scholar
• McCarthy CJ, Gervais DA. Decision Making: thermal Ablation Options for Small Renal Masses. Semin Intervent Radiol. 2017;34(2):167–175. doi:10.1055/s-0037-1602708
   PubMed Web of Science ®Google Scholar
• Pierorazio PM, Johnson MH, Patel HD, et al. Management of Renal Masses and Localized Renal Cancer: systematic Review and Meta-Analysis. J Urol. 2016;196(4):989–999. doi:10.1016/j.juro.2016.04.081
   PubMed Web of Science ®Google Scholar
• Alam R, Patel HD, Osumah T, et al. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study. BJU Int. 2019;123(1):42–50. doi:10.1111/bju.14490
   PubMed Web of Science ®Google Scholar
• Klett DE, Tsivian M, Packiam VT, et al. Partial versus radical nephrectomy in clinical T2 renal masses. Int J Urol. 2021;28(11):1149–1154. doi:10.1111/iju.14664
   PubMed Web of Science ®Google Scholar
• Kopp RP, Mehrazin R, Palazzi KL, et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int. 2014;114(5):708–718. doi:10.1111/bju.12580
   PubMed Web of Science ®Google Scholar
• Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010;183(3):903–908. doi:10.1016/j.juro.2009.11.037
   PubMed Web of Science ®Google Scholar
• Long CJ, Canter DJ, Kutikov A, et al. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int. 2012;109(10):1450–1456. doi:10.1111/j.1464-410X.2011.10608.x
   PubMed Web of Science ®Google Scholar
• Bertolo R, Autorino R, Simone G, et al. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: a Multicenter Analysis (ROSULA Collaborative Group). Eur Urol. 2018;74(2):226–232. doi:10.1016/j.eururo.2018.05.004
   PubMed Web of Science ®Google Scholar
• Bradshaw AW, Autorino R, Simone G, et al. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU Int. 2020;126(1):114–123. doi:10.1111/bju.15064
   PubMed Web of Science ®Google Scholar
• Amparore D, Pecoraro A, Piramide F, et al. Comparison between minimally-invasive partial and radical nephrectomy for the treatment of clinical T2 renal masses: results of a 10-year study in a tertiary care center. Minerva Urol Nephrol. 2021;73(4):509–517. doi:10.23736/S2724-6051.21.04390-1
   PubMedGoogle Scholar
• Yim K, Aron M, Rha KH, et al. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: a Multicenter Analysis. Eur Urol Focus. 2021;7(5):1107–1114. doi:10.1016/j.euf.2020.10.011
   PubMedGoogle Scholar
• Andrade HS, Zargar H, Akca O, et al. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center. J Endourol. 2017;31(2):153–157. doi:10.1089/end.2016.0622
   PubMed Web of Science ®Google Scholar
• Patel SH, Uzzo RG, Larcher A, et al. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: a Multi-institutional Analysis. Clin Genitourin Cancer. 2020;18(6):e723–e729. doi:10.1016/j.clgc.2020.05.002
   PubMed Web of Science ®Google Scholar
• Shvero A, Nativ O, Abu-Ghanem Y, et al. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer. Clin Genitourin Cancer. 2018;16(3):e613–e617. doi:10.1016/j.clgc.2017.10.016
   PubMed Web of Science ®Google Scholar
• Maurice MJ, Zhu H, Kim S, Abouassaly R. Survival after partial and radical nephrectomy for high-risk disease: a propensity-matched comparison. Can Urol Assoc J. 2016;10(9–10):E282–E289. doi:10.5489/cuaj.3707
   PubMedGoogle Scholar
• Ghali F, Elbakry AA, Hamilton ZA, et al. Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis. World J Urol. 2020;38(5):1113–1122. doi:10.1007/s00345-019-02994-2
   PubMed Web of Science ®Google Scholar
• Malkoc E, Ramirez D, Kara O, et al. Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience. World J Urol. 2017;35:781–787. doi:10.1007/s00345-016-1937-9
   PubMed Web of Science ®Google Scholar
• Kim JK, Lee H, Oh JJ, et al. Comparison of robotic and open partial nephrectomy for highly complex renal tumors (RENAL nephrometry score ≥10). PLoS One. 2019;14(1):e0210413. doi:10.1371/journal.pone.0210413
   PubMed Web of Science ®Google Scholar
• Chiappini B, Savini C, Marinelli G, et al. Cavoatrial tumor thrombus: single-stage surgical approach with profound hypothermia and circulatory arrest, including a review of the literature. J Thorac Cardiovasc Surg. 2002;124(4):684–688. doi:10.1067/mtc.2002.124295
   PubMed Web of Science ®Google Scholar
• Abaza R. Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy. Eur Urol. 2011;59(4):652–656. doi:10.1016/j.eururo.2010.08.038
   PubMed Web of Science ®Google Scholar
• Wang B, Li H, Ma X, et al. Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: different Sides Require Different Techniques. Eur Urol. 2016;69(6):1112–1119. doi:10.1016/j.eururo.2015.12.001
   PubMed Web of Science ®Google Scholar
• Abaza R, Shabsigh A, Castle E, et al. Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy. J Urol. 2016;195(4 Pt 1):865–871. doi:10.1016/j.juro.2015.09.094
   PubMed Web of Science ®Google Scholar
• Chopra S, Simone G, Metcalfe C, et al. Robot-assisted Level II-III Inferior Vena Cava Tumor Thrombectomy: step-by-Step Technique and 1-Year Outcomes. Eur Urol. 2017;72(2):267–274. doi:10.1016/j.eururo.2016.08.066
   PubMed Web of Science ®Google Scholar
• Wang B, Huang Q, Liu K, et al. Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: initial Series with Step-by-step Procedures and 1-yr Outcomes. Eur Urol. 2020;78(1):77–86. doi:10.1016/j.eururo.2019.04.019
   PubMed Web of Science ®Google Scholar
• Huang MM, Schwen ZR, Biles MJ, et al. A comparative analysis of surgical scar cosmesis based on operative approach for radical prostatectomy. J Endourol. 2021;35:138–143. doi:10.1089/end.2020.0649
   PubMed Web of Science ®Google Scholar
• Kopp RP, Silberstein JL, Derweesh IH. Laparo-endoscopic single-site (LESS) radical nephrectomy with renal vein thrombectomy: initial report. BMC Urol. 2010;10:8. doi:10.1186/1471-2490-10-8
   PubMed Web of Science ®Google Scholar
• Richstone L, Rais-Bahrami S, Waingankar N, et al. Pfannenstiel laparoendoscopic single-site (LESS) vs conventional multiport laparoscopic live donor nephrectomy: a prospective randomized controlled trial. BJU Int. 2013;112(5):616–622. doi:10.1111/bju.12202
   PubMed Web of Science ®Google Scholar
• Derweesh IH. Whither the long march of LESS. J Urol. 2012;187(5):1531–1532. doi:10.1016/j.juro.2012.02.010
   PubMed Web of Science ®Google Scholar
• Harrison R, Ahmed M, Billah M, et al. Single-port versus multiport partial nephrectomy: a propensity-score-matched comparison of perioperative and short-term outcomes. J Robot Surg. 2022. doi:10.1007/s11701-022-01415-8
   PubMed Web of Science ®Google Scholar
• Glaser ZA, Burns ZR, Fang AM, et al. Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirements. J Robot Surg. 2022;16(3):695–703. doi:10.1007/s11701-021-01271-y
   PubMed Web of Science ®Google Scholar
• Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63(3):486–492. doi:10.1016/j.eururo.2012.08.062
   PubMed Web of Science ®Google Scholar
• Takaki H, Soga N, Kanda H, et al. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology. 2014;270(1):292–299. doi:10.1148/radiol.13130221
   PubMed Web of Science ®Google Scholar
• Ma Y, Bedir S, Cadeddu JA, Gahan JC. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int. 2014;113(1):51–55. doi:10.1111/bju.12366
   PubMed Web of Science ®Google Scholar
• Knox J, Kohlbrenner R, Kolli K, et al. Intermediate to Long-Term Clinical Outcomes of Percutaneous Cryoablation for Renal Masses. J Vasc Interv Radiol. 2020;31(8):1242–1248. doi:10.1016/j.jvir.2020.02.021
   PubMed Web of Science ®Google Scholar
• Pecoraro A, Palumbo C, Knipper S, et al. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer. J Urol. 2019;202(6):1120–1126. doi:10.1097/JU.0000000000000460
   PubMed Web of Science ®Google Scholar
• Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: a Single-Center, Retrospective Study. Radiology. 2017;284(1):272–280. doi:10.1148/radiol.2016160592
   PubMed Web of Science ®Google Scholar
• Guo J, Arellano RS. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors. AJR Am J Roentgenol. 2021;216(1):117–124. doi:10.2214/AJR.20.22818
   PubMed Web of Science ®Google Scholar
• Guo J, Arellano RS. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety. J Endourol. 2020;34(10):1021–1027. doi:10.1089/end.2020.0382
   PubMed Web of Science ®Google Scholar
• Shapiro DD, Wells SA, Best SL, et al. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery. Urology. 2020;135:88–94. doi:10.1016/j.urology.2019.09.024
   PubMed Web of Science ®Google Scholar
• Weight CJ, Miller DC, Campbell SC, Derweesh IH, Lane BR, Messing EM. The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney. J Urol. 2013;189(4):1198–1202. doi:10.1016/j.juro.2013.01.030
   PubMed Web of Science ®Google Scholar